Avantor, Inc.: 6 Major Game-Changers Impacting Its 2025 Performance & Beyond!

Avantor, a global supplier of materials and services for the life sciences and advanced technology industries, reported its fourth-quarter 2024 financial results, indicating a mix of positive and challenging elements in its performance. Avantor noted a return to low single-digit organic growth across the enterprise, a milestone that aligns with the broader market recovery. The bioprocessing business, in particular, showed strong performance for a fourth consecutive quarter, achieving high single-digit organic growth. This sector’s resilience is significant, considering its critical role in Avantor’s portfolio, driven by increased customer engagement and a strong order intake. The adjusted EBITDA margin expanded to 18.2%, the highest in over a year, thanks to a favorable mix and ongoing cost transformation efforts.